CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,400,000 | -47.4% | 835,842 | 0.0% | 0.10% | -35.8% |
| Q2 2019 | $10,264,000 | -9.4% | 835,842 | 0.0% | 0.16% | -9.1% |
| Q1 2019 | $11,326,000 | +237.9% | 835,842 | 0.0% | 0.18% | +182.3% |
| Q4 2018 | $3,352,000 | -40.4% | 835,842 | 0.0% | 0.06% | -8.8% |
| Q3 2018 | $5,625,000 | – | 835,842 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $53,209,000 | 43.12% |
| Ponoi Management, LLC | 1,880,623 | $63,565,000 | 35.32% |
| Column Group LLC | 2,626,631 | $88,780,000 | 12.57% |
| Euclidean Capital LLC | 554,325 | $18,736,000 | 6.08% |
| Chicago Capital Management, LLC | 295,878 | $10,001,000 | 5.60% |
| COMMODORE CAPITAL LP | 440,869 | $14,901,000 | 5.19% |
| Samson Rock Capital LLP | 467,072 | $15,787,000 | 3.11% |
| S. MUOIO & CO. LLC | 105,000 | $3,549,000 | 3.01% |
| Omni Partners US LLC | 1,815,117 | $61,351,000 | 2.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $21,008,000 | 2.68% |